Tristan Rupp

Dr. Tristan Rupp

Porsolt (France), Mayenne, France
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2018 in Cancer Research
Verified
Journal Article
Closed access
PDF file
ZSZhen Sun
Zhen Sun
ASAnja Schwenzer
Anja Schwenzer
Tristan RuppTristan Rupp
Tristan Rupp
DMDevadarssen Murdamoothoo
Devadarssen Murdamoothoo
RVRolando Vegliante
Rolando Vegliante
GOGertraud Orend
Gertraud Orend
Tenascin-C is an extracellular matrix molecule that drives progression of many types of human cancer, but the basis for its actions remains obscure. In this study, we describe a cell-autonomous signaling mechanism explaining how tenascin-C promotes cancer cell migration in the tumor microenvironment. In a murine xenograft model of advanced human osteosarcoma, tenascin-C and its receptor integrin α9β1 were determined to be essential for lung metastasis of tumor cells. We determined that activation of this pathway also reduced tumor cell–autonomous expression of target genes for the transcription factor YAP. In clinical specimens, a genetic signature comprising four YAP target genes represents prognostic impact. Taken together, our results illuminate how tumor cell deposition of tenascin-C in the tumor microenvironment promotes invasive migration and metastatic progression. Significance: These results illuminate how the extracellular matrix glycoprotein tenascin-C in the tumor microenvironment promotes invasive migration and metastatic progression by employing integrin α9β1, abolishing actin stress fiber formation, inhibiting YAP and its target gene expression, with potential implications for cancer prognosis and therapy. Cancer Res; 78(4); 950–61. ©2017 AACR.
1

1 October 2013 in Cell Reports
Verified
Journal Article
Open access
FSFalk Saupe
Falk Saupe
ASAnja Schwenzer
Anja Schwenzer
YJYundan Jia
Yundan Jia
IGIsabelle Gasser
Isabelle Gasser
CSCaroline Spenlé
Caroline Spenlé
GOGertraud Orend
Gertraud Orend
The extracellular matrix molecule tenascin-C (TNC) is a major component of the cancer-specific matrix, and high TNC expression is linked to poor prognosis in several cancers. To provide a comprehensive understanding of TNC's functions in cancer, we established an immune-competent transgenic mouse model of pancreatic β-cell carcinogenesis with varying levels of TNC expression and compared stochastic neuroendocrine tumor formation in abundance or absence of TNC. We show that TNC promotes tumor cell survival, the angiogenic switch, more and leaky vessels, carcinoma progression, and lung micrometastasis. TNC downregulates Dickkopf-1 (DKK1) promoter activity through the blocking of actin stress fiber formation, activates Wnt signaling, and induces Wnt target genes in tumor and endothelial cells. Our results implicate DKK1 downregulation as an important mechanism underlying TNC-enhanced tumor progression through the provision of a proangiogenic tumor microenvironment.
1

1 December 2016 in Cell Reports
Verified
Journal Article
Open access
Tristan RuppTristan Rupp
Tristan Rupp
BLBenoit Langlois
Benoit Langlois
MKMaria M. Koczorowska
Maria M. Koczorowska
ARAgata Radwanska
Agata Radwanska
ZSZhen Sun
Zhen Sun
GOGertraud Orend
Gertraud Orend
High expression of the extracellular matrix component tenascin-C in the tumor microenvironment correlates with decreased patient survival. Tenascin-C promotes cancer progression and a disrupted tumor vasculature through an unclear mechanism. Here, we examine the angiomodulatory role of tenascin-C. We find that direct contact of endothelial cells with tenascin-C disrupts actin polymerization, resulting in cytoplasmic retention of the transcriptional coactivator YAP. Tenascin-C also downregulates YAP pro-angiogenic target genes, thus reducing endothelial cell survival, proliferation, and tubulogenesis. Glioblastoma cells exposed to tenascin-C secrete pro-angiogenic factors that promote endothelial cell survival and tubulogenesis. Proteomic analysis of their secretome reveals a signature, including ephrin-B2, that predicts decreased survival of glioma patients. We find that ephrin-B2 is an important pro-angiogenic tenascin-C effector. Thus, we demonstrate dual activities for tenascin-C in glioblastoma angiogenesis and uncover potential targeting and prediction opportunities.
1

7 October 2014 in Oncotarget
Verified
Journal Article
Open access
PDF file
BLBenoit Langlois
Benoit Langlois
FSFalk Saupe
Falk Saupe
Tristan RuppTristan Rupp
Tristan Rupp
CAChristiane Arnold
Christiane Arnold
MHMichaël van der Heyden
Michaël van der Heyden
THThomas Hussenet
Thomas Hussenet
AngioMatrix, a signature of the tumor angiogenic switch-specific matrisome, correlates with poor prognosis for glioma and colorectal cancer patients AngioMatrix, a signature of the tumor angiogenic switch-specific matrisome, correlates with poor prognosis for glioma and colorectal cancer patients
1

24 March 2022 in Translational Oncology
Verified
Journal Article
Open access
Tristan RuppTristan Rupp
Tristan Rupp
LGLaurie Genest
Laurie Genest
DBDavid Babin
David Babin
CLChristophe Legrand
Christophe Legrand
MHMarion Hunault
Marion Hunault
VCVincent Castagné
Vincent Castagné
• Anti-PD-1 and anti-CTLA-4 induced anti-tumor response in breast cancer mouse model. • Anti-PD-1 and anti-CTLA-4 induced anti-tumor response in colon cancer mouse model. • Anti-CTLA-4 reduced colon cancer–derived lung metastasis formation in a mouse model. • We identified specific T cell response between anti-PD-1 and anti-CTLA-4.
1

6 October 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ARAgata Radwanska
Agata Radwanska
DGDominique Grall
Dominique Grall
SSSébastien Schaub
Sébastien Schaub
SDStéphanie Beghelli-De la Forest Divonne
Stéphanie Beghelli-De la Forest Divonne
DCDelphine Ciais
Delphine Ciais
EOEllen Van Obberghen-Schilling
Ellen Van Obberghen-Schilling
Cellular fibronectin (FN) and tenascin-C (TNC) are prominent development- and disease-associated matrix components with pro- and anti-adhesive activity, respectively. Whereas both are present in the tumour vasculature, their functional interplay on vascular endothelial cells remains unclear. We have previously shown that basally-oriented deposition of a FN matrix restricts motility and promotes junctional stability in cultured endothelial cells and that this effect is tightly coupled to expression of FN. Here we report that TNC induces FN expression in endothelial cells. This effect counteracts the potent anti-adhesive activity of TNC and leads to the assembly of a dense highly-branched subendothelial matrix that enhances tubulogenic activity. These findings suggest that pro-angiogenic remodelling of the perivascular matrix may involve TNC-induced upregulation of FN in endothelial cells.
1